Innate and adaptive immune responses in Parkinson's disease
Open accessThe DOI matches its Crossref record; 108 of the 108 references it cites were found in a registry or an index.
Abstract
Parkinson’s disease (PD) has classically been defined as a movement disorder, in which motor symptoms are explained by the aggregation of alpha-synuclein (α-syn) and subsequent death of dopaminergic neurons of the substantia nigra pars compacta (SNpc). More recently, the multisystem effects of the disease have been investigated, with the immune system being implicated in a number of these processes in the brain, the blood, and the gut. In this review, we highlight the dysfunctional immune system found in both human PD and animal models of the disease, and discuss how genetic risk factors and risk modifiers are associated with pro-inflammatory immune responses. Finally, we emphasize evidence that the immune response drives the pathogenesis and progression of PD, and discuss key questions that remain to be investigated in order to identify immunomodulatory therapies in PD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED ARTICLE: Parkin and PINK1 mitigate STING-induced inflammation
Sliter, D. A., Martinez, J., Hao, L., Chen, X., Sun, N., Fischer, T. D., Burman, J. L., Li, Y., Zhang, Z., Narendra, D. P., et al. (2018) · Nature · doi:10.1038/s41586-018-0448-9 · Cited by 1,287 · cited 2×
“It has been shown that individuals with mono or biallelic mutations in parkin, regardless of PD status, have higher amounts of pro-inflammatory cytokines and chemokines (IL-6, IL-1β, CCL2, and CCL4) in their serum compared to controls (Sliter et al., 2018).”
BackgroundRetractedA Unique Microglia Type Associated with Restricting Development of Alzheimer’s Disease
Keren-Shaul, H., Spinrad, A., Weiner, A., Matcovitch-Natan, O., Dvir-Szternfeld, R., Ulland, T. K., David, E., Baruch, K., Lara-Astaiso, D., Toth, B., et al. (2017) · Cell · doi:10.1016/j.cell.2017.05.018 · Cited by 5,493
Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog Synthesis
Langston, J. W., Ballard, P., Tetrud, J. W., & Irwin, I. (1983) · Science · doi:10.1126/science.6823561 · Cited by 4,914
Sokol, H., Pigneur, B., Watterlot, L., Lakhdari, O., Bermúdez-Humarán, L. G., Gratadoux, J.-J., Blugeon, S., Bridonneau, C., Furet, J.-P., Corthier, G., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804812105 · Cited by 4,413
α-Synuclein Locus Triplication Causes Parkinson's Disease
Singleton, A. B., Farrer, M., Johnson, J., Singleton, A., Hague, S., Kachergus, J., Hulihan, M., Peuralinna, T., Dutra, A., Nussbaum, R., et al. (2003) · Science · doi:10.1126/science.1090278 · Cited by 4,383 · cited 1×
“…only strengthened the findings that the hallmark PD protein and the genetic control of its expression are a major determining factor for the development of familial or idiopathic Parkinson’s disease (Chartier-Harlin et al., 2004; Edwards et al., 2010; Kruger et al., 1998; Singleton et al., 2003).”
BackgroundInteractions Between the Microbiota and the Immune System
Hooper, L. V., Littman, D. R., & Macpherson, A. J. (2012) · Science · doi:10.1126/science.1223490 · Cited by 4,173 · cited 2×
“Not only is the microbiome important in overall gut function, it is also now better appreciated for its role in shaping as well as being shaped by the host’s immune system (Hooper et al., 2012).”
BackgroundAlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease
Krüger, R., Kuhn, W., Müller, T., Woitalla, D., Graeber, M., Kösel, S., Przuntek, H., Epplen, J. T., Schols, L., & Riess, O. (1998) · Nature Genetics · doi:10.1038/ng0298-106 · Cited by 3,836 · cited 5×
“, 1997) that results in an alanine to threonine substitution and A30P (Kruger et al., 1998) that results in an alanine to proline substitution, have been identified in multiple human cohorts.”
BackgroundInfluentialMcGeer, P. L., Itagaki, S., Boyes, B. E., & McGeer, E. G. (1988) · Neurology · doi:10.1212/wnl.38.8.1285 · Cited by 2,990
Microglia Function in the Central Nervous System During Health and Neurodegeneration
Colonna, M., & Butovsky, O. (2017) · Annual Review of Immunology · doi:10.1146/annurev-immunol-051116-052358 · Cited by 2,894
Trained immunity: A program of innate immune memory in health and– disease
Netea, M. G., Joosten, L. A. B., Latz, E., Mills, K. H. G., Natoli, G., Stunnenberg, H. G., O’Neill, L. A. J., & Xavier, R. J. (2016) · Science · doi:10.1126/science.aaf1098 · Cited by 2,768
Cytokines in inflammatory bowel disease
Neurath, M. F. (2014) · Nature Reviews Immunology · doi:10.1038/nri3661 · Cited by 2,706 · cited 4×
“Inflammatory bowel disease (IBD) patients, a population who are at higher risk of developing PD (Lin et al., 2016; Peter et al., 2018), who were on anti-TNF treatments had a 78% reduction in their PD incidence rate compared to IBD Prog Brain Res.”
BackgroundInfluentialLuk, K. C., Kehm, V., Carroll, J., Zhang, B., O’Brien, P., Trojanowski, J. Q., & Lee, V. M.-Y. (2012) · Science · doi:10.1126/science.1227157 · Cited by 2,563
The Roles of PINK1, Parkin, and Mitochondrial Fidelity in Parkinson’s Disease
Pickrell, A. M., & Youle, R. J. (2015) · Neuron · doi:10.1016/j.neuron.2014.12.007 · Cited by 2,310
Overview of the immune response
Chaplin, D. D. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.12.980 · Cited by 2,235 · cited 1×
“B cells can also obtain help from T cells to produce high-affinity antibodies (also called immunoglobulins, Igs) that rapidly recognize and clear immunological threats (Chaplin, 2010).”
Backgroundα-synuclein locus duplication as a cause of familial Parkinson's disease
Chartier-Harlin, M.-C., Kachergus, J., Roumier, C., Mouroux, V., Douay, X., Lincoln, S., Levecque, C., Larvor, L., Andrieux, J., Hulihan, M., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17103-1 · Cited by 2,029
Gut microbiota are related to Parkinson's disease and clinical phenotype
Scheperjans, F., Aho, V., Pereira, P. A. B., Koskinen, K., Paulin, L., Pekkonen, E., Haapaniemi, E., Kaakkola, S., Eerola‐Rautio, J., Pohja, M., et al. (2015) · Movement Disorders · doi:10.1002/mds.26069 · Cited by 1,968
Interactions between the microbiota, immune and nervous systems in health and disease
Fung, T. C., Olson, C. A., & Hsiao, E. Y. (2017) · Nature Neuroscience · doi:10.1038/nn.4476 · Cited by 1,900
The microbiota in adaptive immune homeostasis and disease
Honda, K., & Littman, D. R. (2016) · Nature · doi:10.1038/nature18848 · Cited by 1,846
The Role of Oxidative Stress in Parkinson's Disease
Dias, V., Junn, E., & Mouradian, M. M. (2013) · Journal of Parkinson’s Disease · doi:10.3233/jpd-130230 · Cited by 1,845
Lambrecht, B. N., & Hammad, H. (2015) · Nature Immunology · doi:10.1038/ni.3049 · Cited by 1,673 · cited 2×
“, 2015) along with non-CNS allergic or autoimmune responses that have heavy humoral influence, such as asthma (Lambrecht and Hammad, 2015).”
BackgroundKim, S., Kwon, S.-H., Kam, T.-I., Panicker, N., Karuppagounder, S. S., Lee, S., Lee, J. H., Kim, W. R., Kook, M., Foss, C. A., et al. (2019) · Neuron · doi:10.1016/j.neuron.2019.05.035 · Cited by 1,397 · cited 1×
“…vivo models where the extent of spread, and whether it is across only one synapse or multiple, even spreading to neuroanatomical regions that are not directly connected, has been a source of much disagreement within the field (Grozdanov and Danzer, 2018; Kim et al., 2019; Sorrentino et al., 2017).”
BackgroundBraak, H., de Vos, R. A. I., Bohl, J., & Del Tredici, K. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2005.11.012 · Cited by 1,354 · cited 2×
“While α-syn pathology is typically discussed in relation to the CNS, inclusions are also found in the colon, in neurons of the enteric nervous system, and within the vagus nerve itself (Braak et al., 2006; Shannon et al., 2012).”
BackgroundOrigin, fate and dynamics of macrophages at central nervous system interfaces
Goldmann, T., Wieghofer, P., Jordão, M. J. C., Prutek, F., Hagemeyer, N., Frenzel, K., Amann, L., Staszewski, O., Kierdorf, K., Krueger, M., et al. (2016) · Nature Immunology · doi:10.1038/ni.3423 · Cited by 1,209
In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease
Gerhard, A., Pavese, N., Hotton, G., Turkheimer, F., Es, M., Hammers, A., Eggert, K., Oertel, W., Banati, R. B., & Brooks, D. J. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.08.002 · Cited by 1,200 · cited 1×
“, 2000), as well as through the use of positron emission tomography (PET) imaging studies (Gerhard et al., 2006; Iannaccone et al., 2013; Terada et al., 2016).”
BackgroundWu, D. C., Jackson-Lewis, V., Vila, M., Tieu, K., Teismann, P., Vadseth, C., Choi, D.-K., Ischiropoulos, H., & Przedborski, S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-05-01763.2002 · Cited by 1,183
Brochard, V., Combadière, B., Prigent, A., Laouar, Y., Perrin, A., Beray-Berthat, V., Bonduelle, O., Alvarez-Fischer, D., Callebert, J., Launay, J.-M., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36470 · Cited by 1,172 · cited 4×
“This includes the infiltration of CD4 and CD8 T cells (Benner et al., 2008; Brochard et al., 2009; Kurkowska-Jastrzebska et al., 1999; Reynolds et al., 2010) as well as B cell mediated IgG deposition (Benner et al.”
BackgroundInfluentialMicroglia development and function
Nayak, D., Roth, T. L., & McGavern, D. B. (2014) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032713-120240 · Cited by 1,154
Block of A1 astrocyte conversion by microglia is neuroprotective in models of Parkinson’s disease
Yun, S. P., Kam, T.-I., Panicker, N., Kim, S., Oh, Y., Park, J.-S., Kwon, S.-H., Park, Y. J., Karuppagounder, S. S., Park, H., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0051-5 · Cited by 1,123 · cited 6×
“Therefore, in these ways, α-syn acts similar to a foreign antigen, PAMP, or DAMP that would typically activate an APC.”
BackgroundInfluentialCognitive decline in Parkinson disease
Aarsland, D., Creese, B., Politis, M., Chaudhuri, K. R., ffytche, D. H., Weintraub, D., & Ballard, C. (2017) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.27 · Cited by 1,027 · cited 1×
“An even larger portion (30–80%) of PD patients will develop dementia, with half of non-demented patients still displaying mild cognitive impairment and cognitive decline over time (Aarsland et al., 2017).”
BackgroundGastrointestinal Dysfunction in Parkinson’s Disease
Fasano, A., Visanji, N. P., Liu, L. W. C., Lang, A. E., & Pfeiffer, R. F. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)00007-1 · Cited by 1,016
Mrdjen, D., Pavlovic, A., Hartmann, F. J., Schreiner, B., Utz, S. G., Leung, B. P., Lelios, I., Heppner, F. L., Kipnis, J., Merkler, D., et al. (2018) · Immunity · doi:10.1016/j.immuni.2018.01.011 · Cited by 1,010
Mogi, M., Harada, M., Riederer, P., Narabayashi, H., Fujita, K., & Nagatsu, T. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90746-3 · Cited by 986
Multiple sclerosis: a complicated picture of autoimmunity
McFarland, H. F., & Martin, R. (2007) · Nature Immunology · doi:10.1038/ni1507 · Cited by 985 · cited 1×
“However, there are instances where autoimmune Th1 responses occur, as is the case in patients with MS (McFarland and Martin, 2007) or inflammatory bowel disease (IBD) (Neurath, 2014), where they can promote destructive tissue damage through excessive cytokine release and innate immune system activation.”
BackgroundForsyth, C. B., Shannon, K. M., Kordower, J. H., Voigt, R. M., Shaikh, M., Jaglin, J. A., Estes, J. D., Dodiya, H. B., & Keshavarzian, A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028032 · Cited by 974
A gut-brain neural circuit for nutrient sensory transduction
Kaelberer, M. M., Buchanan, K. L., Klein, M. E., Barth, B. B., Montoya, M. M., Shen, X., & Bohórquez, D. V. (2018) · Science · doi:10.1126/science.aat5236 · Cited by 932 · cited 1×
“Braak’s hypothesis attempts to tie these two phenotypes together by suggesting that a pathogen could pass through the leaky intestinal wall of presymptomatic PD patients and promote the formation of abnormal α-syn species across the GI tract and enteric nervous system—a hypothesis that has only grown more feasible wit…”
BackgroundInflammasome inhibition prevents α-synuclein pathology and dopaminergic neurodegeneration in mice
Gordon, R., Albornoz, E. A., Christie, D. C., Langley, M. R., Kumar, V., Mantovani, S., Robertson, A. A. B., Butler, M. S., Rowe, D. B., O’Neill, L. A., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aah4066 · Cited by 897
Hill‐Burns, E. M., Debelius, J. W., Morton, J. T., Wissemann, W. T., Lewis, M. R., Wallen, Z. D., Peddada, S. D., Factor, S. A., Molho, E., Zabetian, C. P., et al. (2017) · Movement Disorders · doi:10.1002/mds.26942 · Cited by 874 · cited 1×
“Therefore, it is not surprising that multiple studies have observed alterations in the microbiomes of diverse cohorts of people with PD across the world (Aho et al., 2019; Barichella et al., 2019; Hill-Burns et al., 2017; Li et al., 2017; Lin et al., 2019; Petrov et al., 2017; Pietrucci et al., 2019; Scheperjans et al…”
BackgroundSelf-citationT cells from patients with Parkinson’s disease recognize α-synuclein peptides
Sulzer, D., Alcalay, R. N., Garretti, F., Cote, L., Kanter, E., Agin-Liebes, J., Liong, C., McMurtrey, C., Hildebrand, W. H., Mao, X., et al. (2017) · Nature · doi:10.1038/nature22815 · Cited by 866 · cited 6×
“The idea of T cell driven neuroinflammation is further supported by evidence from (Sulzer et al., 2017), who exposed patient PBMCs to various α-syn peptides, and found cytokine responses from CD4 and CD8 T cells.”
BackgroundResultInfluentialObeso, J. A., Stamelou, M., Goetz, C. G., Poewe, W., Lang, A. E., Weintraub, D., Burn, D., Halliday, G. M., Bezard, E., Przedborski, S., et al. (2017) · Movement Disorders · doi:10.1002/mds.27115 · Cited by 859
Self-citationKim, C., Ho, D.-H., Suk, J.-E., You, S., Michael, S., Kang, J., Joong Lee, S., Masliah, E., Hwang, D., Lee, H.-J., et al. (2013) · Nature Communications · doi:10.1038/ncomms2534 · Cited by 856 · cited 3×
“Particularly, toll-like receptors on microglia can be activated by αsyn, similar to a PAMP or DAMP (Daniele et al., 2015; Fellner et al., 2013; Kim et al., 2013, 2016; Sanchez-Guajardo et al., 2015; Yun et al., 2018).”
BackgroundFrequency of Bowel Movements and the Future Risk of Parkinson’s Disease
Abbott, R. D., Petrovitch, H., White, L. R., Masaki, K. H., Tanner, C. M., Curb, J. D., Grandinetti, A., Blanchette, P. L., Popper, J. S., & Ross, G. W. (2001) · Neurology · doi:10.1212/wnl.57.3.456 · Cited by 839 · cited 1×
“It has been observed that constipation in PD patients begins long before the onset of motor symptoms, and that fewer bowel movements per day are associated with a higher risk for PD (Abbott et al., 2001).”
BackgroundA meta‐analysis of coffee drinking, cigarette smoking, and the risk of Parkinson's disease
Hernán, M. A., Takkouche, B., Caamaño‐Isorna, F., & Gestal‐Otero, J. J. (2002) · Annals of Neurology · doi:10.1002/ana.10277 · Cited by 818 · cited 1×
“These same general findings have been observed in subsequent studies using a variety of different cohorts (Chen et al., 2005; Gao et al., 2011; Hernan et al., 2002; Powers et al., 2008).”
ResultBlum-Degena, D., Müller, T., Kuhn, W., Gerlach, M., Przuntek, H., & Riederer, P. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)12192-7 · Cited by 801
Imamura, K., Hishikawa, N., Sawada, M., Nagatsu, T., Yoshida, M., & Hashizume, Y. (2003) · Acta Neuropathologica · doi:10.1007/s00401-003-0766-2 · Cited by 791
Regulatory T cells in autoimmune disease
Dominguez-Villar, M., & Hafler, D. A. (2018) · Nature Immunology · doi:10.1038/s41590-018-0120-4 · Cited by 713 · cited 2×
“This response often fails to resolve itself, especially since IL-10 producing Tregs are impaired in either number or function in many autoimmune conditions (Dominguez-Villar and Hafler, 2018; Miyara et al., 2011).”
BackgroundToll‐like receptor 4 is required for α‐synuclein dependent activation of microglia and astroglia
Fellner, L., Irschick, R., Schanda, K., Reindl, M., Klimaschewski, L., Poewe, W., Wenning, G. K., & Stefanova, N. (2013) · Glia · doi:10.1002/glia.22437 · Cited by 697
Plasma exosomal α-synuclein is likely CNS-derived and increased in Parkinson’s disease
Shi, M., Liu, C., Cook, T. J., Bullock, K. M., Zhao, Y., Ginghina, C., Li, Y., Aro, P., Dator, R., He, C., et al. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1314-y · Cited by 676 · cited 1×
“However, in humans, brain derived exosomes have been found to contain elevated levels of α-syn that correlate with disease severity (more α-syn correlated with worse disease measures) (Shi et al., 2014).”
BackgroundThe role of peripheral immune cells in the CNS in steady state and disease
Prinz, M., & Priller, J. (2017) · Nature Neuroscience · doi:10.1038/nn.4475 · Cited by 657 · cited 2×
“This review and others (Prinz and Priller, 2017) use a specific definition of inflammation encompassing all three of these responses.”
BackgroundMethodColonic inflammation in Parkinson's disease
Devos, D., Lebouvier, T., Lardeux, B., Biraud, M., Rouaud, T., Pouclet, H., Coron, E., Bruley des Varannes, S., Naveilhan, P., Nguyen, J.-M., et al. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.09.007 · Cited by 627 · cited 24×
“[PubMed: 19104149] Brodacki B, Staszewski J, Toczylowska B, Kozlowska E, Drela N, Chalimoniuk M, Stepien A, 2008 Serum interleukin (IL-2, IL-10, IL-6, IL-4), TNFalpha, and INFgamma concentrations are elevated in patients with atypical and idiopathic parkinsonism.”
BackgroundInfluentialA new fate mapping system reveals context-dependent random or clonal expansion of microglia
Tay, T. L., Mai, D., Dautzenberg, J., Fernández-Klett, F., Lin, G., Sagar, Datta, M., Drougard, A., Stempfl, T., Ardura-Fabregat, A., et al. (2017) · Nature Neuroscience · doi:10.1038/nn.4547 · Cited by 597
The multiple pathways to autoimmunity
Theofilopoulos, A. N., Kono, D. H., & Baccala, R. (2017) · Nature Immunology · doi:10.1038/ni.3731 · Cited by 590
Parkinson’s Disease-Related Proteins PINK1 and Parkin Repress Mitochondrial Antigen Presentation
Matheoud, D., Sugiura, A., Bellemare-Pelletier, A., Laplante, A., Rondeau, C., Chemali, M., Fazel, A., Bergeron, J. J., Trudeau, L.-E., Burelle, Y., et al. (2016) · Cell · doi:10.1016/j.cell.2016.05.039 · Cited by 582
Mogi, M., Harada, M., Narabayashi, H., Inagaki, H., Minami, M., & Nagatsu, T. (1996) · Neuroscience Letters · doi:10.1016/0304-3940(96)12706-3 · Cited by 545
Zhou, L., Zhang, M., Wang, Y., Dorfman, R. G., Liu, H., Yu, T., Chen, X., Tang, D., Xu, L., Yin, Y., et al. (2018) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izy182 · Cited by 525
Polarization of the Effects of Autoimmune and Neurodegenerative Risk Alleles in Leukocytes
Raj, T., Rothamel, K., Mostafavi, S., Ye, C., Lee, M. N., Replogle, J. M., Feng, T., Lee, M., Asinovski, N., Frohlich, I., et al. (2014) · Science · doi:10.1126/science.1249547 · Cited by 506 · cited 1×
“Interestingly, this potential PD-variant genetic effect on immune cells may be more direct than we think as (Raj et al., 2014) observed an overrepresentation of immune-specific expression quantitative trait loci (eQTL) overlapping with PD susceptibility loci (e.”
BackgroundRockenstein, E., Mallory, M., Hashimoto, M., Song, D., Shults, C. W., Lang, I., & Masliah, E. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10231 · Cited by 502 · cited 1×
“…overexpress full length human α-syn under the Thy1, PDGF-β, or even the rat TH promoters develop intracellular inclusions (Fleming et al., 2004, 2011; Masliah et al., 2000; Rockenstein et al., 2002), and some develop decreases in striatal dopamine levels (Lam et al., 2011; Masliah et al., 2000).”
BackgroundIntestinal infection triggers Parkinson's disease-like symptoms in Pink1(-/-) mice
Matheoud, D., Cannon, T., Voisin, A., Penttinen, A.-M., Ramet, L., Fahmy, A. M., Ducrot, C., Laplante, A., Bourque, M.-J., Zhu, L., et al. (2019) · Nature · doi:10.1038/s41586-019-1405-y · Cited by 496 · cited 1×
“…two recent studies performed in mice reported activation of the adaptive immune system, through the induction of pro-inflammatory cytotoxic CD8 T cells targeting host mitochondrial antigens in PINK1 or Parkin deficient mice subjected to bacterial exposure (Matheoud et al., 2016, 2019).”
BackgroundAnalysis of Gut Microbiota in Patients with Parkinson’s Disease
Petrov, V. A., Saltykova, I. V., Zhukova, I. A., Alifirova, V. M., Zhukova, N. G., Dorofeeva, Y. B., Tyakht, A. V., Kovarsky, B. A., Alekseev, D. G., Kostryukova, E. S., et al. (2017) · Bulletin of Experimental Biology and Medicine · doi:10.1007/s10517-017-3700-7 · Cited by 487 · cited 1×
“Therefore, it is not surprising that multiple studies have observed alterations in the microbiomes of diverse cohorts of people with PD across the world (Aho et al., 2019; Barichella et al., 2019; Hill-Burns et al., 2017; Li et al., 2017; Lin et al., 2019; Petrov et al., 2017; Pietrucci et al., 2019; Scheperjans et al…”
BackgroundAltered gut microbiota and inflammatory cytokine responses in patients with Parkinson's disease
Lin, C.-H., Chen, C.-C., Chiang, H.-L., Liou, J.-M., Chang, C.-M., Lu, T.-P., Chuang, E. Y., Tai, Y.-C., Cheng, C., Lin, H.-Y., et al. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1528-y · Cited by 469 · cited 1×
“Therefore, it is not surprising that multiple studies have observed alterations in the microbiomes of diverse cohorts of people with PD across the world (Aho et al., 2019; Barichella et al., 2019; Hill-Burns et al., 2017; Li et al., 2017; Lin et al., 2019; Petrov et al., 2017; Pietrucci et al., 2019; Scheperjans et al…”
BackgroundAlpha-synuclein in colonic submucosa in early untreated Parkinson’s disease
Shannon, K. M., Keshavarzian, A., Mutlu, E., Dodiya, H. B., Daian, D., Jaglin, J. A., & Kordower, J. H. (2012) · Movement Disorders · doi:10.1002/mds.23838 · Cited by 469
Cosenza‐Nashat, M., Zhao, M. ‐., Suh, H. ‐., Morgan, J., Natividad, R., Morgello, S., & Lee, S. C. (2009) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2008.01006.x · Cited by 459 · cited 1×
“In the PET studies, ligands are specific to the translocator protein, TSPO (previously referred to as the “peripheral benzodiazepine receptor”), a protein that is expressed on the mitochondrial membrane of activated myeloid cells and astrocytes (Cosenza-Nashat et al., 2009; Lavisse et al., 2012).”
BackgroundGenetics in Parkinson disease: Mendelian versus non‐Mendelian inheritance
Hernandez, D. G., Reed, X., & Singleton, A. B. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13593 · Cited by 448
Croisier, E., Moran, L. B., Dexter, D. T., Pearce, R. K., & Graeber, M. B. (2005) · Journal of Neuroinflammation · doi:10.1186/1742-2094-2-14 · Cited by 414
Harms, A. S., Cao, S., Rowse, A. L., Thome, A. D., Li, X., Mangieri, L. R., Cron, R. Q., Shacka, J. J., Raman, C., & Standaert, D. G. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.5610-12.2013 · Cited by 406
Self-citationLi, W., Wu, X., Hu, X., Wang, T., Liang, S., Duan, Y., Jin, F., & Qin, B. (2017) · Science China Life Sciences · doi:10.1007/s11427-016-9001-4 · Cited by 406
McGeer, P. L., Schwab, C., Parent, A., & Doudet, D. (2003) · Annals of Neurology · doi:10.1002/ana.10728 · Cited by 400 · cited 1×
“In mice and nonhuman primates, MPTP treatment leads to robust MHCII+ microglial activation (Czlonkowska et al., 1996; Kohutnicka et al., 1998; Mcgeer et al., 2003).”
BackgroundPeter, I., Dubinsky, M., Bressman, S., Park, A., Lu, C., Chen, N., & Wang, A. (2018) · JAMA Neurology · doi:10.1001/jamaneurol.2018.0605 · Cited by 386 · cited 2×
“Inflammatory bowel disease (IBD) patients, a population who are at higher risk of developing PD (Lin et al., 2016; Peter et al., 2018), who were on anti-TNF treatments had a 78% reduction in their PD incidence rate compared to IBD Schonhoff et al.”
BackgroundResultHui, K. Y., Fernandez-Hernandez, H., Hu, J., Schaffner, A., Pankratz, N., Hsu, N.-Y., Chuang, L.-S., Carmi, S., Villaverde, N., Li, X., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aai7795 · Cited by 384
Ontogeny of Tissue-Resident Macrophages
Hoeffel, G., & Ginhoux, F. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00486 · Cited by 364 · cited 2×
“The exact identity of these reactive “microglia” still remains to be determined, as it is possible that some may be peripherally derived macrophages of a monocyte lineage rather than true microglia (Hoeffel and Ginhoux, 2015) (Fig.”
BackgroundGut microbiota in Parkinson's disease: Temporal stability and relations to disease progression
Aho, V. T. E., Pereira, P. A. B., Voutilainen, S., Paulin, L., Pekkonen, E., Auvinen, P., & Scheperjans, F. (2019) · eBioMedicine · doi:10.1016/j.ebiom.2019.05.064 · Cited by 361
A Progressive Mouse Model of Parkinson’s Disease: The Thy1-aSyn (“Line 61”) Mice
Chesselet, M.-F., Richter, F., Zhu, C., Magen, I., Watson, M. B., & Subramaniam, S. R. (2012) · Neurotherapeutics · doi:10.1007/s13311-012-0104-2 · Cited by 346 · cited 2×
“In the case of α-syn, it seems as if overabundance of α-syn is enough to lead to hyperphosphorylation, ubiquitylation, and aggregation (Chesselet et al., 2012; Fleming et al., 2004; Masliah et al., 2000).”
BackgroundMHC-I expression renders catecholaminergic neurons susceptible to T-cell-mediated degeneration
Cebrián, C., Zucca, F. A., Mauri, P., Steinbeck, J. A., Studer, L., Scherzer, C. R., Kanter, E., Budhu, S., Mandelbaum, J., Vonsattel, J. P., et al. (2014) · Nature Communications · doi:10.1038/ncomms4633 · Cited by 338 · cited 2×
“, 2002) and detrimental to neuron health (Cebrian et al., 2014; Filiano et al., 2017).”
BackgroundPrognosis and neuropathologic correlation of clinical subtypes of Parkinson disease
De Pablo-Fernández, E., Lees, A. J., Holton, J. L., & Warner, T. T. (2019) · JAMA Neurology · doi:10.1001/jamaneurol.2018.4377 · Cited by 332
Th17 lymphocytes induce neuronal cell death in a human iPSC-based model of Parkinson's disease
Sommer, A., Marxreiter, F., Krach, F., Fadler, T., Grosch, J., Maroni, M., Graef, D., Eberhardt, E., Riemenschneider, M. J., Yeo, G. W., et al. (2018) · Cell Stem Cell · doi:10.1016/j.stem.2018.06.015 · Cited by 332
Brodacki, B., Staszewski, J., Toczyłowska, B., Kozłowska, E., Drela, N., Chalimoniuk, M., & Stępien, A. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.06.040 · Cited by 316 · cited 3×
“Another more recent study has recapitulated these above findings but also found increased levels of TNF, IFN-γ, and IL-10 in the CSF of PD patients (Brodacki et al., 2008).”
BackgroundResultMartín, R., Miquel, S., Chain, F., Natividad, J. M., Jury, J., Lu, J., Sokol, H., Theodorou, V., Bercik, P., Verdu, E. F., et al. (2015) · BMC Microbiology · doi:10.1186/s12866-015-0400-1 · Cited by 309
The identity and function of microglia in neurodegeneration
Song, W. M., & Colonna, M. (2018) · Nature Immunology · doi:10.1038/s41590-018-0212-1 · Cited by 308 · cited 2×
“In fact, these DAMs have been found to be consistently present across many models of neurodegeneration, including models of Alzheimer’s disease, ALS, and multiple sclerosis (Song and Colonna, 2018).”
BackgroundDaniele, S. G., Béraud, D., Davenport, C., Cheng, K., Yin, H., & Maguire-Zeiss, K. A. (2015) · Science Signaling · doi:10.1126/scisignal.2005965 · Cited by 303 · cited 7×
“Therefore, in these ways, α-syn acts similar to a foreign antigen, PAMP, or DAMP that would typically activate an APC.”
BackgroundInfluentialInflammatory dysregulation of blood monocytes in Parkinson’s disease patients
Grozdanov, V., Bliederhaeuser, C., Ruf, W. P., Roth, V., Fundel-Clemens, K., Zondler, L., Brenner, D., Martin-Villalba, A., Hengerer, B., Kassubek, J., et al. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1345-4 · Cited by 295 · cited 3×
“It has been shown that individuals with mono or biallelic mutations in parkin, regardless of PD status, have higher amounts of pro-inflammatory cytokines and chemokines (IL-6, IL-1β, CCL2, and CCL4) in their serum compared to controls (Sliter et al., 2018).”
BackgroundMartín, R., Chain, F., Miquel, S., Lu, J., Gratadoux, J.-J., Sokol, H., Verdu, E. F., Bercik, P., Bermúdez-Humarán, L. G., & Langella, P. (2014) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000440815.76627.64 · Cited by 284
Dzamko, N., Gysbers, A., Perera, G., Bahar, A., Shankar, A., Gao, J., Fu, Y., & Halliday, G. M. (2017) · Acta Neuropathologica · doi:10.1007/s00401-016-1648-8 · Cited by 273
Sanchez-Guajardo, V., Febbraro, F., Kirik, D., & Romero-Ramos, M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008784 · Cited by 256 · cited 1×
“AAV2/5 is used in rats and leads to increased expression of MHCII and CD68, and infiltration CD4 and CD8 T cells in the midbrain (Sanchez-Guajardo et al., 2010).”
BackgroundCX3CL1 reduces neurotoxicity and microglial activation in a rat model of Parkinson’s disease
Pabon, M. M., Bachstetter, A. D., Hudson, C. E., Gemma, C., & Bickford, P. C. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-9 · Cited by 241
Harms, A. S., Thome, A. D., Yan, Z., Schonhoff, A. M., Williams, G. P., Li, X., Liu, Y., Qin, H., Benveniste, E. N., & Standaert, D. G. (2018) · Experimental Neurology · doi:10.1016/j.expneurol.2017.11.010 · Cited by 236 · cited 1×
“, 2018), or CCR2 knockout (Harms et al., 2018), which prevents CCR2+ inflammatory monocyte migration to tissues, are protective against neurodegeneration.”
BackgroundSelf-citationMundt, S., Mrdjen, D., Utz, S. G., Greter, M., Schreiner, B., & Becher, B. (2019) · Science Immunology · doi:10.1126/sciimmunol.aau8380 · Cited by 235
Iannaccone, S., Cerami, C., Alessio, M., Garibotto, V., Panzacchi, A., Olivieri, S., Gelsomino, G., Moresco, R. M., & Perani, D. (2013) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2012.07.002 · Cited by 221 · cited 1×
“, 2000), as well as through the use of positron emission tomography (PET) imaging studies (Gerhard et al., 2006; Iannaccone et al., 2013; Terada et al., 2016).”
BackgroundFaecalibacterium prausnitzii supernatant improves intestinal barrier function in mice DSS colitis
Carlsson, A. H., Yakymenko, O., Olivier, I., Håkansson, F., Postma, E., Keita, Å. V., & Söderholm, J. D. (2013) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521.2013.828773 · Cited by 219 · cited 1×
“, 2008), and promotion of gut barrier health (Carlsson et al., 2013; Martin et al., 2015).”
BackgroundMarinova‐Mutafchieva, L., Sadeghian, M., Broom, L., Davis, J. B., Medhurst, A. D., & Dexter, D. T. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06189.x · Cited by 217 · cited 1×
“In this model, activation of the CNS innate immune system, first described by (Akiyama and Mcgeer, 1989), has been shown to precede overt neuron loss (Cicchetti et al., 2002; Depino et al., 2003; Marinova-Mutafchieva et al., 2009), suggesting that the priming of these inflammatory myeloid cells may help drive this neu…”
MethodDysbiosis of gut microbiota in a selected population of Parkinson's patients
Pietrucci, D., Cerroni, R., Unida, V., Farcomeni, A., Pierantozzi, M., Mercuri, N. B., Biocca, S., Stefani, A., & Desideri, A. (2019) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2019.06.003 · Cited by 217
Estimating T-cell repertoire diversity: limitations of classical estimators and a new approach
Laydon, D. J., Bangham, C. R. M., & Asquith, B. (2015) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2014.0291 · Cited by 215 · cited 1×
“The number of possible unique TCRs or BCRs is estimated to be in the 1013 range (Calis and Rosenberg, 2014; Laydon et al., 2015) and allows recognition of a wide range of bacterial, viral, or fungal antigens in a highly specific manner.”
BackgroundKuhlmann, A. C., & Guilarte, T. R. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0741694.x · Cited by 215 · cited 1×
“This is also a key issue with the TSPO based PET scanning, as this ligand is not specific to microglia or even immune cells—indeed it has been shown to bind to astrocytes (Kuhlmann and Guilarte, 2000; Pannell et al., 2019).”
BackgroundHow and why do T cells and their derived cytokines affect the injured and healthy brain?
Filiano, A. J., Gadani, S. P., & Kipnis, J. (2017) · Nature Reviews Neuroscience · doi:10.1038/nrn.2017.39 · Cited by 199 · cited 34×
“Outside of the CNS, an exciting area of research is exploring the link between CNS and dysfunctions in the gastrointestinal tract, most notably preclinical constipation (Fasano et al., 2015) and associated intestinal inflammation in patients with PD (Devos et al., 2013).”
BackgroundInfluentialLewy body-like alpha-synuclein inclusions trigger reactive microgliosis prior to nigral degeneration
Duffy, M. F., Collier, T. J., Patterson, J. R., Kemp, C. J., Luk, K. C., Tansey, M. G., Paumier, K. L., Kanaan, N. M., Fischer, D. L., Polinski, N. K., et al. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1171-z · Cited by 197
Human gut symbiont roseburia hominis promotes and regulates innate immunity
Patterson, A. M., Mulder, I. E., Travis, A. J., Lan, A., Cerf-Bensussan, N., Gaboriau-Routhiau, V., Garden, K., Logan, E., Delday, M. I., Coutts, A. G. P., et al. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01166 · Cited by 192
Vitetta, E. S., Berton, M. T., Burger, C., Kepron, M., Lee, W. T., & Yin, X. M. (1991) · Annual Review of Immunology · doi:10.1146/annurev.iy.09.040191.001205 · Cited by 187
Lam, H. A., Wu, N., Cely, I., Kelly, R. L., Hean, S., Richter, F., Magen, I., Cepeda, C., Ackerson, L. C., Walwyn, W., et al. (2011) · Journal of Neuroscience Research · doi:10.1002/jnr.22611 · Cited by 184 · cited 1×
“…overexpress full length human α-syn under the Thy1, PDGF-β, or even the rat TH promoters develop intracellular inclusions (Fleming et al., 2004, 2011; Masliah et al., 2000; Rockenstein et al., 2002), and some develop decreases in striatal dopamine levels (Lam et al., 2011; Masliah et al., 2000).”
Backgroundα-Synuclein fibrils recruit peripheral immune cells in the rat brain prior to neurodegeneration
Harms, A. S., Delic, V., Thome, A. D., Bryant, N., Liu, Z., Chandra, S., Jurkuvenaite, A., & West, A. B. (2017) · Acta Neuropathologica Communications · doi:10.1186/s40478-017-0494-9 · Cited by 181
Self-citationAn updated review of Parkinson's disease genetics and clinicopathological correlations
Ferreira, M., & Massano, J. (2017) · Acta Neurologica Scandinavica · doi:10.1111/ane.12616 · Cited by 167 · cited 1×
“Mutations in LRRK2 that cause PD are associated with increased kinase activity, and these increases are also observed in PD patients without a LRRK2 mutation (Di Maio et al., 2018; Ferreira and Massano, 2017).”
BackgroundMutant α-Synuclein Overexpression Mediates Early Proinflammatory Activity
Su, X., Federoff, H. J., & Maguire-Zeiss, K. A. (2009) · Neurotoxicity Research · doi:10.1007/s12640-009-9053-x · Cited by 145 · cited 1×
“…in the substantia nigra and striatum, increased numbers of IBA1+ cells (which could represent microglia or infiltrating myeloid cells), increased levels of TNF in both the substantia nigra and striatum, increased cytokine and ROS production, as well as decreased IL-10 levels (Su et al., 2009).”
BackgroundZhu, C., Song, K., Shen, Z., Quan, Y., Tan, B., Luo, W., Wu, S., Tang, K., Yang, Z., & Wang, X. (2018) · Molecular Medicine Reports · doi:10.3892/mmr.2018.8833 · Cited by 144 · cited 8×
“Moreover, Th1 (IFN-γ) and Th17 (IL-17a) polarized T cells adoptively transferred into MPTP intoxicated mice exacerbated SN TH+ neuron loss, while Th2 (IL-4), Treg (IL-10), and vasoactive intestinal peptide (VIP, a neuropeptide associated with Treg responses) treated mice did not.”
BackgroundInfluentialSacino, A. N., Brooks, M., McKinney, A. B., Thomas, M. A., Shaw, G., Golde, T. E., & Giasson, B. I. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.2102-14.2014 · Cited by 141 · cited 1×
“Human PFFs injected into M20 human α-syn-expressing mice leads to increased GFAP and IBA1 immunostaining, indicative of astrocytosis and a myeloid response (Sacino et al., 2014; Sorrentino et al., 2017).”
Backgroundβ-Synuclein-reactive T cells induce autoimmune CNS grey matter degeneration
Lodygin, D., Hermann, M., Schweingruber, N., Flügel-Koch, C., Watanabe, T., Schlosser, C., Merlini, A., Körner, H., Chang, H.-F., Fischer, H. J., et al. (2019) · Nature · doi:10.1038/s41586-019-0964-2 · Cited by 140 · cited 1×
“These data have been recapitulated in part by Lodygin et al. (2019), who found that blood circulating α-synreactive CD4 T cells were expanded in PD patients.”
BackgroundShen, Z., Zhu, C., Quan, Y., Yang, J., Yuan, W., Yang, Z., Wu, S., Luo, W., Tan, B., & Wang, X. (2018) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.14144 · Cited by 133
Pannell, M., Economopoulos, V., Wilson, T. C., Kersemans, V., Isenegger, P. G., Larkin, J. R., Smart, S., Gilchrist, S., Gouverneur, V., & Sibson, N. R. (2020) · Glia · doi:10.1002/glia.23716 · Cited by 109
Neuroprotection by the selective iNOS inhibitor GW274150 in a model of Parkinson disease
Broom, L., Marinova-Mutafchieva, L., Sadeghian, M., Davis, J. B., Medhurst, A. D., & Dexter, D. T. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.12.026 · Cited by 96 · cited 1×
“, 2011), iNOS inhibitors (Broom et al., 2011), or dominant negative anti-TNF therapy (Harms et al.”
BackgroundNon-cell-autonomous Neurotoxicity of α-synuclein Through Microglial Toll-like Receptor 2
Kim, C., Lee, H.-J., Masliah, E., & Lee, S.-J. (2016) · Experimental Neurobiology · doi:10.5607/en.2016.25.3.113 · Cited by 92 · cited 2×
“Particularly, toll-like receptors on microglia can be activated by αsyn, similar to a PAMP or DAMP (Daniele et al., 2015; Fellner et al., 2013; Kim et al., 2013, 2016; Sanchez-Guajardo et al., 2015; Yun et al., 2018).”
BackgroundSorrentino, Z. A., Brooks, M. M. T., Hudson, V., Rutherford, N. J., Golde, T. E., Giasson, B. I., & Chakrabarty, P. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0182-z · Cited by 79
Activated microglial cells and complement factors are unrelated to cortical Lewy bodies
Rozemuller, A. J. M., Eikelenboom, P., Theeuwes, J. W., Jansen Steur, E. N. H., & de Vos, R. A. I. (2000) · Acta Neuropathologica · doi:10.1007/s004010000225 · Cited by 50 · cited 1×
“Regardless of their exact origin, multiple groups have provided further evidence of a pro-inflammatory phenotype (HLA-DR+, CD68+, ICAM-1+) or innate activation (increased TLR2 expression) through histological studies (Croisier et al., 2005; Dzamko et al., 2017; Imamura et al., 2003; Orr et al., 2005; Rozemuller et al.…”
Background
Cited by
LRRK2 activation in idiopathic Parkinson’s disease
Di Maio, R., Hoffman, E. K., Rocha, E. M., Keeney, M. T., Sanders, L. H., De Miranda, B. R., Zharikov, A., Van Laar, A., Stepan, A. F., Lanz, T. A., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aar5429 · Cited by 564
Metagenomics of Parkinson’s disease implicates the gut microbiome in multiple disease mechanisms
Wallen, Z. D., Demirkan, A., Twa, G., Cohen, G., Dean, M. N., Standaert, D. G., Sampson, T. R., & Payami, H. (2022) · Nature Communications · doi:10.1038/s41467-022-34667-x · Cited by 346
Self-citationCD4 T cells mediate brain inflammation and neurodegeneration in a mouse model of Parkinson's disease
Williams, G. P., Schonhoff, A. M., Jurkuvenaite, A., Gallups, N. J., Standaert, D. G., & Harms, A. S. (2021) · Brain · doi:10.1093/brain/awab103 · Cited by 306
Mundt, S., Mrdjen, D., Utz, S. G., Greter, M., Schreiner, B., & Becher, B. (2019) · Science Immunology · doi:10.1126/sciimmunol.aau8380 · Cited by 235
Schonhoff, A. M., Figge, D. A., Williams, G. P., Jurkuvenaite, A., Gallups, N. J., Childers, G. M., Webster, J. M., Standaert, D. G., Goldman, J. E., & Harms, A. S. (2023) · Nature Communications · doi:10.1038/s41467-023-39060-w · Cited by 161
Self-citation
Metadata
- Venue
- Progress in Brain Research
- Publisher
- Elsevier
- Published
- 2020
- Volume
- 252
- Pages
- 169-216
- ISSN
- 0079-6123 (ISSN-L)
- OpenAlex
- W2992020634
- Cited by
- 116
- References
- 108
- FWCI
- 37.13
- Type
- book chapter
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.